Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.890
-0.050 (-2.58%)
At close: Mar 3, 2026, 4:00 PM EST
1.880
-0.010 (-0.52%)
Pre-market: Mar 4, 2026, 8:37 AM EST
CRDF's stock price has decreased by -55.42% in the past year and price targets may not have had time to catch up.
Cardiff Oncology Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$9.63
Upside
+409.52%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +217.46% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +429.10% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $10 | Strong Buy | Maintains | $18 → $10 | +429.10% | Aug 6, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +905.29% | Jul 8, 2025 |
| Jefferies | Jefferies | Hold Initiates $3.5 | Hold | Initiates | $3.5 | +85.19% | Jun 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $18 | Strong Buy | Maintains | $17 → $18 | +852.38% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $17 | Strong Buy | Maintains | $13 → $17 | +799.47% | Feb 28, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $10 | Buy | Maintains | $7 → $10 | +429.10% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +587.83% | Nov 8, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +323.28% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +640.74% | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +640.74% | Mar 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +270.37% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +534.92% | Aug 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +587.83% | Aug 8, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +640.74% | May 9, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.